Back
Zai Lab Ltd (ZLAB) Price
ZLAB Stock Price Chart
ZLAB Financial
Zai Lab Ltd
$18.58
-1.27%
$-0.24
At close: Jan 16, 16:00:00 GMT-5
$18.58
0%
$0
Post-market: Jan 16, 20:00:00 GMT-5
Income
Balance sheet
Cash flow
Annual
Quarterly
ZLAB Income
Financials in millions USD. Fiscal year is February - January.
Follow-Up Questions
What are Zai Lab Ltd's key financial statements?
What are the key financial ratios for ZLAB?
How is Zai Lab Ltd's revenue broken down by segment or geography?
Is Zai Lab Ltd profitable?
Does Zai Lab Ltd have any liabilities?
How many outstanding shares for Zai Lab Ltd?
Key Stats
Prev.Close
$18.82
Open
$18.67
Day's Range
$18.42 - $18.86
52 week range
$16.82 - $44.34
Volume
516.0K
Avg.Volume
893.0K
EPS (TTM)
-1.90
Dividend yield
--
Market Cap
$2.0B
What is ZLAB?
Zai Lab Ltd. is a biopharmaceutical company, which engages in the developing and commercializing therapies that address medical conditions with unmet needs in oncology, autoimmune disorders, infectious diseases, and neuroscience. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2020-09-28. The firm is committed to addressing the unmet medical needs in the fields of tumors, autoimmune diseases, infectious diseases and central nervous system diseases through product discovery, development and commercialization. The firm has a series of patented drug candidates from the discovery stage to the late clinical project. These include ZEJULA, OPTUNE, QINLOCK, NUZYRA and VYVGART, and others.
Features
Trading Strategies
Resources
© 2025 Finture Development Limited. All rights reserved